Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• Zimmer Biomet Spotlights ROSA Shoulder and Signature Vision Navigation at ICSES 2026: As reported by OrthoSpineNews, Zimmer Biomet showcased its comprehensive shoulder portfolio featuring the ROSA® Shoulder System for robotic resection alongside Signature Vision™ mixed reality navigation to enhance accuracy in complex arthroplasty.
• ORTHOWORLD Reports on $11 Billion Spine Market Driven by Enabling Technologies: Published in BONEZONE, ORTHOWORLD analysis highlights that tier-one players Medtronic and Globus Medical command 43% of the global spine sector, where procedural volume competition is increasingly dictated by robotic and digital planning ecosystems.
• HSS Study Confirms Equivalent 1-Year Outcomes for MIS vs. Open Lapidus Arthrodesis: As reported by Healio Orthopedics, Level-II clinical data presented at AOFAS showed percutaneous Lapidus achieves deformity correction and union rates comparable to open surgery with reduced soft-tissue disruption.
• Just Medical SK Knee System Cleared: Just Medical Devices (Tianjin) Co., Ltd. secured FDA 510(k) clearance (K253961) for the SK Knee System indicated for semi-constrained total knee arthroplasty.
• Spineart SCALA TL Cleared: Spineart SA received FDA 510(k) clearance (K261049) for the SCALA® TL interbody system indicated for transforaminal lumbar interbody fusion (TLIF).

DAILY ANNOUNCEMENTS BY CATEGORY

Surgical Robotics, AI & Navigation

Zimmer Biomet — Complete Shoulder Solutions Showcase at ICSES 2026 Highlights ROSA Shoulder System and Signature Vision Mixed Reality Navigation

• Summary: Zimmer Biomet announced its comprehensive shoulder portfolio showcase at the 16th International Congress of Shoulder and Elbow Surgery (ICSES 2026), spotlighting expanded robotic and holographic navigation capabilities. The updated ROSA® Shoulder System delivers robotically assisted glenoid reaming and humeral resection across anatomic and reverse total shoulder arthroplasty, while Signature Vision™ provides compact, real-time mixed reality holographic instrument tracking integrated within the surgeon's direct line of sight.
• Key Details:
  • Device/System Name: ROSA® Shoulder System & Signature Vision™ Mixed Reality
  • Status: Commercial Showcase / Expanded FDA 510(k) Cleared Platform
  • Clinical Significance: Enhances surgical accuracy during difficult glenoid version correction and humeral resection in reverse and anatomic shoulder arthroplasty while streamlining operating room footprint via heads-up holographic display.
• Original Source: OrthoSpineNews

Spine & Orthobiologics

ORTHOWORLD — State of the Spine Market Analysis Highlights $11 Billion Sector Driven by Enabling Technologies and Consolidating Tier-One Competition

• Summary: ORTHOWORLD's spine sector intelligence published in BONEZONE evaluates the $11 billion worldwide spine market, which accounts for 17% of all global orthopaedic device sales. With Medtronic and Globus Medical commanding a combined 43% market share, competition has shifted decisively to digital surgical ecosystems—encompassing navigation, robotics, and pre-operative planning—as mid-tier innovators fight for procedural volume in a mature segment.
• Key Details:
  • Device/System Name: Global Spine Market Intelligence (ORTHOWORLD Analysis)
  • Status: Market Analysis / Commercial Intelligence
  • Clinical Significance: Illustrates how surgical robotics, navigation, and pre-operative digital planning are increasingly determinative for hospital procurement decisions and procedural market share.
• Original Source: BONEZONE

Trauma & Extremities

Hospital for Special Surgery — Comparative Trial Validates Equivalent 1-Year Outcomes Between Minimally Invasive and Open Lapidus Procedures for Hallux Valgus

• Summary: In clinical evidence presented at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting, researchers led by Dr. Scott J. Ellis at Hospital for Special Surgery demonstrated that minimally invasive (MIS) Lapidus arthrodesis achieves deformity correction, union rates, and patient-reported outcomes equivalent to conventional open Lapidus procedures at one year. The findings provide objective Level-II evidence supporting surgeon adoption of percutaneous first tarsometatarsal joint preparation and fixation without compromising durability.
• Key Details:
  • Device/System Name: Minimally Invasive (MIS) vs. Open First TMT Arthrodesis
  • Status: Clinical Study / AOFAS Annual Meeting Presentation
  • Clinical Significance: Confirms that percutaneous Lapidus techniques provide comparable correction of severe hallux valgus while offering smaller incisions and reduced soft-tissue disruption compared to standard open approaches.
• Original Source: Healio Orthopedics

RECENTLY INDEXED FDA 510(k) & PMA CLEARANCES — ORTHOPAEDIC

Note: The openFDA database typically indexes clearances 2–4 weeks after the official decision date. Dates shown reflect the FDA decision date, not the indexing date.